Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Using evidence and being open-minded are 2 strategies for providers shifting to new models of delivering care, says Lee A. Norman, MD, MHS, MBA, senior medical director for Optum Care Kansas City.
Transcript
What role can physicians play in driving innovation and leadership in health care, particularly when it comes to adopting new models of care?
The role of physicians in how to lead in a value-based care world is one that I think we really have to be creative and innovative, because we need better and stronger models for care. Physicians should be open-minded to looking at new and challenging different ways to do things. Sometimes it means, as I said earlier, using evidence to change our practices, because there are certain things, quite honestly, that don't work. And yet they're very traditionally implemented. And we see lots of those specifically, in neurologic situations. A lot of cardiac, a lot of excess imaging is done, that doesn't really have a payback in terms of the clinical quality.
And then finally, clinical quality indicators. The data is getting more robust all the time, and we need to pay attention to outcomes, and especially where there is disparities and outcomes, we have to understand why. B physicians can lead by being creative and innovative, and it's really important to be open-minded.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More